IOL’S EXTENDED DIOPTRE RANGE

IOL’S EXTENDED DIOPTRE RANGE
Colin Kerr
Colin Kerr
Published: Thursday, October 1, 2020
AcuFocus, Inc. has announced that the IC-8 small aperture intraocular lens (IOL) power range now extends from +10.0D to +30.0D (0.50D steps). “Having the IC-8 IOL in my practice has provided an exceptional option for my patients who are looking for spectacle independence,” says Professor Sathish Srinivasan, cataract and refractive surgery specialist at University Hospital Ayr, Scotland, and Medical Director of Ayrshire Eye Clinic. Clinical studies demonstrate the IC-8 IOL produces unparalleled visual outcomes that deliver nearly 3.00D of continuous and uninterrupted range of vision compensation for up to 1.50D of corneal astigmatism and excellent image quality,” he said. www.acufocus.com
Latest Articles
ESCRS Today 2025: Happy Anniversaries!

ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.

Read more...

ESCRS Today 2025: A Congress for Everyone

From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.

Read more...

ESCRS Today 2025: All Eyes on Innovation

Watching out for obstacles and opportunities

Read more...

Beyond the Numbers

Empowering patient participation fosters continuous innovation in cataract surgery.

Read more...

Thinking Beyond the Surgery Room

Practice management workshop focuses on financial operations and AI business applications.

Read more...

Aid Cuts Threaten Global Eye Care Progress

USAID closure leads retreat in development assistance.

Read more...

Supplement: ESCRS Clinical Trends Series: Presbyopia

Read more...

Debate: FS-LASIK or KLEx for Hyperopia?

FS-LASIK has more of a track record, but KLEx offers advantages.

Read more...

Four AI Applications Ready for Practice

Commercial offerings may save time, improve practice and research.

Read more...

Perioperative Medication Regimens for Cataract Surgery

Randomised controlled clinical trial results provide evidence-based guidance.

Read more...